 Connection
Yuki Fujiwara to Chemokine CXCL10
This is a "connection" page, showing publications Yuki Fujiwara has written about Chemokine CXCL10.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.600 |
|
|
|
-
Li L, Kanemitsu K, Ohnishi K, Yamada R, Yano H, Fujiwara Y, Miyamoto Y, Mikami Y, Hibi T, Baba H, Komohara Y. CXCL10 Expression in Human Colorectal Cancer Tissue and its Correlation With Serum Levels of CXCL10. Cancer Genomics Proteomics. 2024 Jan-Feb; 21(1):54-64.
Score: 0.212
-
Miura Y, Motoshima T, Anami T, Yano H, Mito R, Pan C, Urakami S, Kinowaki K, Tsukamoto H, Kurahashi R, Murakami Y, Yatsuda J, Fujiwara Y, Kamba T, Komohara Y. Predictive value of CXCL10 for the occurrence of immune-related adverse events in patient with renal cell carcinoma. Microbiol Immunol. 2023 Jul; 67(7):345-354.
Score: 0.202
-
Torphy RJ, Sun Y, Lin R, Caffrey-Carr A, Fujiwara Y, Ho F, Miller EN, McCarter MD, Lyons TR, Schulick RD, Kedl RM, Zhu Y. GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models. Nat Commun. 2022 01 10; 13(1):97.
Score: 0.185
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|